Namenda (Memantine) — Patient Guide (Australia)

Namenda is a medicine containing memantine. It is used for certain types of memory loss conditions. This guide explains how it works, how it is taken, what to expect, and important safety information for people in Australia.

Note: Everyone’s situation is different. Use this information to understand the medicine and to discuss details with your healthcare professional.

Quick product information

• Active ingredient: Memantine
• Brand name: Namenda
• Medicine type: NMDA receptor antagonist (brain receptor modulator)
• Common form (varies by product): Tablets
• Typical use: Moderate to severe Alzheimer’s disease; sometimes used in other approved clinical contexts
• Availability in Australia: Depending on the specific product strength and formulation, it may be supplied through pharmacy channels

What Namenda is used for

Memantine is used in the treatment of Alzheimer’s disease, particularly moderate to severe disease. It can help with thinking, memory, and ability to perform daily activities for some people.

Important: Namenda is not a cure. It may help slow worsening of symptoms in some individuals, supporting day-to-day function for longer.

Indications (who it may be for)

In Australia, memantine is indicated for Alzheimer’s disease in line with approved product information (for example, moderate to severe stages). Your healthcare professional can confirm whether memantine is appropriate for your specific diagnosis and stage.

How Namenda works (mechanism of action)

In Alzheimer’s disease, nerve cell communication can become disrupted. Memantine works by affecting certain brain receptors involved in learning and memory.

• NMDA receptor antagonist: Memantine helps regulate activity at NMDA (N-methyl-D-aspartate) receptors.
• Reduces excessive signalling: It can help limit overstimulation that may contribute to nerve cell damage.
• Supports balanced neurotransmission: By modulating receptor activity, it may help preserve communication between brain cells.

What you may notice: Symptom improvement is not guaranteed, and the effect may be modest. Many patients benefit by maintaining function rather than experiencing sudden “improvement.”

Pharmacokinetics (how the body handles memantine)

Understanding pharmacokinetics can help explain dosing schedules and why dose adjustments may be needed in certain health conditions.

Absorption

• Memantine is absorbed after oral dosing.
• Its absorption is generally consistent, and it can be taken with or without food (see food section below).

Distribution

• It distributes into body tissues, including the brain.
• Because the medicine acts in the nervous system, consistent dosing helps maintain steady levels.

Metabolism and elimination

• Memantine is partly metabolised in the body.
• It is largely eliminated by the kidneys (via urine).

Half-life

Memantine has a prolonged duration of action, which supports once-daily or twice-daily regimens depending on the product and prescribed schedule.

Kidney function matters

Because memantine is cleared by the kidneys, people with reduced kidney function may need dose adjustments and closer monitoring.

Typical timing and how to take Namenda

Follow your prescriber’s instructions or product label directions. The goal is usually to start at a lower dose and increase gradually to improve tolerance.

Starting and increasing dose (common approach)

Many patients begin with a low dose, then increase in steps over time. This gradual titration is typical for memantine to reduce early side effects such as dizziness or headache.

• Take at the same time each day (or as directed, morning and evening).
• If you miss a dose: Take it when remembered unless it is close to the next dose. Do not take a double dose.

When to take it

Memantine can be taken with or without food. Some people prefer morning dosing if it causes mild alertness changes; others prefer evening dosing if it suits them better. Consistency is key.

Food interactions

Memantine generally has no major food restrictions and can be taken with meals. However, food can influence stomach acidity, which may affect memantine absorption and elimination in some circumstances.

Practical food guidance

• Most patients: Can take memantine with breakfast or with dinner, whichever fits their routine.
• Avoid major changes: Try not to make large, abrupt changes to diet or supplements that significantly alter urine acidity without advice.

Alcohol interactions

Alcohol may worsen memory problems, drowsiness, dizziness, and balance—effects that can overlap with memantine side effects.

• Best approach: Limit or avoid alcohol if you notice increased dizziness, sleepiness, or confusion.
• Safety first: Alcohol can increase fall risk, especially in older adults.

If alcohol use is part of your routine, discuss it with your healthcare professional to determine what level is safest for you.

Medicine interactions (important)

Memantine can interact with other medicines and with substances that affect kidney elimination or urine acidity. Always provide your full medication list (including supplements) to your healthcare professional.

Key interaction categories

• Medicines that affect kidney function (may increase memantine levels)
• Medicines that alter urine acidity (may change memantine elimination)
• Other medicines that influence the brain’s receptor activity (your clinician can assess combined effects)

Examples of substances that may be relevant

• Urine alkalinisers (raising urine pH) may alter drug clearance.
• Changes in pH from diet or antacids can be relevant in some cases.
• Other Alzheimer’s medicines (such as cholinesterase inhibitors) may be used together in some patients—your clinician will determine appropriateness.

Always check before starting new medicines, including:

• Over-the-counter cold/flu products
• Sleep medicines
• Antihistamines (especially older, more sedating ones)
• Herbal products and supplements

Dosing (typical regimen and how it may be adjusted)

Dosing depends on the severity of symptoms, tolerability, age, and kidney function. A clinician usually starts at a lower dose and increases gradually.

General principles

• Start low and go slow to improve tolerability.
• Use the strength and formulation prescribed.
• Kidney impairment: may require lower doses and closer monitoring.

Example titration pattern (illustrative)

Many patients follow a staged increase over several weeks. Because different product strengths and schedules exist, do not rely on this example alone. Always follow your individual prescription or product instructions.

If you tell a pharmacist or clinician what strength you have, they can confirm the exact titration schedule for your specific product.

Missed doses

• If you miss a dose, take it when you remember.
• If it is almost time for the next dose, skip the missed dose.
• Do not take a double dose to catch up.

Safety profile and side effects

Most people tolerate memantine well, but side effects can occur. Side effects may be more noticeable early during dose increases.

Common side effects

• Dizziness
• Headache
• Constipation
• Confusion or sleep-related changes (in some patients)
• Fatigue

Less common but important symptoms

• Severe or persistent confusion changes
• Unusual agitation
• Falls or significant balance problems
• Allergic-type reactions (rare)

Seek urgent medical help if

• There are signs of an allergic reaction (e.g., swelling of face/lips, rash with breathing difficulty)
• There is severe dizziness, fainting, or serious worsening of alertness
• Accidental overdose is suspected

Who needs extra caution?

• People with kidney impairment
• People with a history of falls or balance issues
• People taking medicines that affect the nervous system or urine pH
• Older adults who are more sensitive to dizziness and sedation

Practical tips for using Namenda

Taking memantine consistently can support stable effects. Here are practical strategies that may help.

• Use a medication organiser (weekly blister pack, pillbox) to reduce missed doses.
• Keep a routine—link the dose to a daily habit like breakfast or morning care.
• Track changes: note any improvements or side effects, such as dizziness, constipation, or sleep changes.
• Hydration helps: staying adequately hydrated supports kidney function (unless restricted by your clinician).
• Prevent falls: if you feel dizzy, sit before standing, and ensure good lighting and clear walking paths.
• Caregiver support: if helping someone take tablets, check label directions and follow the titration schedule.

Managing constipation

Constipation can occur with many long-term medicines and with reduced mobility in dementia. If constipation becomes troublesome:

• Discuss stool softeners or fibre options with your pharmacist or healthcare professional.
• Maintain fluid intake and appropriate dietary fibre if safe for you.

When to reassess treatment

Because effects can be gradual, reviews are often scheduled after a few weeks and then periodically. Contact your healthcare professional if symptoms worsen rapidly or if you experience concerning side effects.

Alternative options

If memantine is not suitable, alternatives may be considered depending on diagnosis, stage, and overall health. Your healthcare professional will advise on the best option for your needs.

Other medicine options (commonly used in Alzheimer’s disease)

• Cholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine) — often used for mild to moderate Alzheimer’s, and sometimes continued into more advanced stages.
• Combination approaches — in some patients, memantine is used alongside a cholinesterase inhibitor.

Non-medicine supports

• Memory support strategies and routine building
• Carer education and support services
• Physical activity and balance training if safe
• Speech, occupational, and cognitive therapy approaches where appropriate

Even when using medicines, dementia care is usually most effective when combined with supportive care planning.

Market and legal context for Australia (plain-language)

In Australia, medicines like memantine are regulated through the Therapeutic Goods Administration (TGA). Supply and availability depend on the approved status of the product, formulary requirements, and pharmacy processes.

Online pharmacies generally:

• Source products through approved distribution channels
• Provide information about correct use and safe storage
• May require patient screening or additional steps depending on the product category and local requirements

Always check the product listing for the exact strength, formulation, and any supply conditions.

Recent guidance and monitoring (what matters now)

Guidance for dementia medicines generally emphasises:

• Regular clinical review to confirm benefit and monitor side effects
• Assessment of kidney function where relevant
• Caregiver involvement in observing changes in behaviour, falls, sleep, and daily functioning

If you are starting or switching memantine:

• Ask your clinician how long it may take to notice benefit.
• Clarify the titration schedule and what side effects are expected.
• Confirm whether any lab tests or kidney monitoring are recommended for your situation.

Delivery, availability, and storage

Availability: Namenda may be available through pharmacy supply channels depending on the specific product strength and market listing. In an online pharmacy setting, stock can vary.

Delivery: Most online pharmacies offer standard and express options across Australia. Delivery times depend on your location and the pharmacy’s dispatch schedule. Check the product page for estimated dispatch and delivery timeframes.

Storage tips

• Store tablets according to the label (commonly at room temperature, protected from moisture).
• Keep out of reach of children.
• Do not use tablets after the expiry date.

If you receive a medicine that looks different than usual (e.g., incorrect tablets), contact the pharmacy before using it.

FAQ — Namenda (Memantine)

1) How long does it take for Namenda to work?

Effects can be gradual. Some people and carers notice changes over weeks, while others may see more stabilisation than improvement. Regular follow-up helps determine whether the medicine is helping and whether adjustments are needed.

2) Can Namenda be taken with other Alzheimer’s medicines?

In some patients, memantine is used together with cholinesterase inhibitors. This should be decided by your healthcare professional based on your diagnosis, stage, and tolerability.

3) What should I do if the person taking memantine becomes dizzy?

Stop and seek advice if dizziness is severe or persistent. For milder dizziness, take care when standing, stay hydrated, and inform the healthcare professional—especially if falls occur or balance worsens.

4) Is it safe to drink alcohol while taking memantine?

Alcohol may increase dizziness and confusion and can raise fall risk. Limiting alcohol—or avoiding it—may be safer. Discuss your usual alcohol intake with your healthcare professional.

5) Does memantine cause sleepiness?

Some people experience fatigue or changes in alertness. If sleepiness affects safety (e.g., driving or falls risk), contact a healthcare professional and review other medicines that could contribute.

6) What interactions should I watch for?

Tell your pharmacist or clinician about all medicines (including over-the-counter products and supplements). Particular care may be needed with medicines that affect kidney function or urine acidity.

7) Can I take Namenda with food?

Yes. Memantine can generally be taken with or without food. Choose a time that helps you remember and maintain a consistent routine.

8) What if I have kidney disease?

Kidney function can affect how memantine is cleared. Dose adjustments and monitoring may be needed. Make sure your clinician is aware of any kidney impairment.

9) What side effects are most common?

Common side effects include dizziness, headache, constipation, and sometimes fatigue or sleep-related changes. If side effects are bothersome or worsen, seek advice.

10) When should I seek urgent help?

Seek urgent medical help if you suspect an overdose, have signs of an allergic reaction, fainting, severe confusion, or serious worsening of symptoms.

Final reminder

Namenda (memantine) can support treatment of moderate to severe Alzheimer’s disease for some people. The most important steps are taking it consistently, increasing dose gradually as advised, monitoring for side effects, and keeping regular reviews—especially if kidney function is reduced or other medicines are being used.